In-Vitro Diagnostics Market, By Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other) and by Region (NA, EU, APAC, LA, MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The In-Vitro Diagnostics Market was valued at USD 70,005.6 million in 2020, growing with a 7.7% CAGR during the forecast period, 2021-2027.
In-vitro diagnostics (IVD) are medical devices that use assays and reagents to diagnose a disease. Furthermore, these instruments analyze body tissue and fluid samples taken from patients. Furthermore, there are various types of in vitro diagnostic tools which use various techniques such as tissue diagnostics, immunodiagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are used to diagnose a wide range of medical conditions, including infectious diseases, cardiac disorders, cancer, and nephrological disorders.
Market Dynamics
The major factor contributing to the growth of the in vitro diagnostic market is an increase in the number of in vitro diagnostic tests, which is due to an increase in the incidences of infectious and chronic diseases. Furthermore, the growing geriatric population, which is prone to immunological disorders, is a major factor driving market growth. Furthermore, the increased use of personalized medicines in the treatment of various chronic diseases such as cancer fuels the market's growth. Furthermore, technological advancements associated with in vitro diagnostic technologies, products, software, and services drive market growth.
Product Takeaway
On the basis of product, the reagents segment captured a significant share of the in Vitro diagnostics market. The fact that reagents are an essential component of every in vitro diagnostic test has contributed to the growth of this segment. As a result, the mentioned factors contribute to the expansion of this segment. Furthermore, the instruments segment is expected to grow at the fastest CAGR over the forecast period, owing to a shift in key players' focus towards the launch of new instruments.
Regional Takeaway
North America currently dominates the in-vitro diagnostic market and is expected to do so for the foreseeable future. Because of the region's well-established healthcare industry and rising prevalence of chronic diseases, the above region is expected to increase its market share in the future. Because of rising healthcare costs and the rapid adoption of point-of-care testing, the United States controls the majority of the market in the North American region.
COVID-19 Impact
Since there is an increasing demand for IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV2 virus infection among the global population, the COVID-19 pandemic has focused attention on in-vitro diagnostics. Because in-vitro diagnostics involves testing of various biological samples, the outbreak of COVID-19 is expected to have a positive impact on the market under consideration. This should help with the treatment of various diseases like COVID-19. Testing is still an important step in containing the COVID-19 pandemic. As the percentage of COVID-19 cases increases around the world, government agencies in various countries are considering allowing private labs to ramp up test.
Key Vendor Takeaway
Some of the major players in this industry include Siemens Healthineers, Roche Diagnostics Limited, Abbott Laboratories, Danaher Corporation, Johnson & Johnson, Thermo Fisher Scientific, Dickinson and Company, Becton, Sysmex Corporation, Bio-Rad Laboratories, Diasorin, bioMérieux, Ortho-Clinical Diagnostics, and Qiagen.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2019
- Base Year – 2020
- Projected Year – 2021 to 2027
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS
- Siemens Healthineers
- Roche Diagnostics Limited
- Abbott Laboratories
- Danaher Corporation
- Johnson & Johnson
- Thermo Fisher Scientific
- Dickinson and Company
- Becton
- Sysmex Corporation
- Bio-Rad Laboratories
- Diasorin
- bioMérieux
- Ortho-Clinical Diagnostics
- Qiagen
GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TEST TYPE
- Clinical Chemistry
- Molecular Diagnostics
- Immuno Diagnostics
- Hematology
- Other Test Types
GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT
- Instruments
- Reagents
- Other Products
GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
- Infectious Disease
- Diabetes
- Cancer/Oncology
- Cardiology
- Autoimmune Disease
- Nephrology
- Other
GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. IN-VITRO DIAGNOSTICS MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Test Type
2.1.2. Market Snippet by Product
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. IN-VITRO DIAGNOSTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. IN-VITRO DIAGNOSTICS INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. IN-VITRO DIAGNOSTICS MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. IN-VITRO DIAGNOSTICS MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. IN-VITRO DIAGNOSTICS MARKET – BY TEST TYPE
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2020 & 2027 (%)
7.2. Clinical Chemistry
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.3. Molecular Diagnostics
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.4. Immuno Diagnostics
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.5. Haematology
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.6. Others
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8. IN-VITRO DIAGNOSTICS MARKET – BY-PRODUCTS
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
8.2. Instruments
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.3. Reagents
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.4. Others
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9. IN-VITRO DIAGNOSTICS MARKET – BY APPLICATION
9.1. Overview
9.1.1. Segment Share Analysis, By APPLICATION, 2020 & 2027 (%)
9.2. Infectious Disease
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3. Diabetes
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4. Cancer/Oncology
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5. Cardiology
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6. Autoimmune Disease
9.6.1. Overview
9.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.7. Nephrology
9.7.1. Overview
9.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.8. Others
9.8.1. Overview
9.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10. IN-VITRO DIAGNOSTICS MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.2.6. North America Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.2.8.5. Canada Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.6. Europe Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.7.5. Germany Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.3.8.3. Italy Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.8.4. Italy Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.8.5. Italy Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.3.10.3. France Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.10.4. France Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.10.5. France Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.3.11. Rest of Europe
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.3.11.3. Rest of Europe Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.3.11.4. Rest of Europe Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.3.11.5. Rest of Europe Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.4. Asia Pacific
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.4.5. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.4.7.3. India Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.4.7.4. India Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.4.7.5. India Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.4.8.3. China Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.4.8.4. China Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.4.8.5. China Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.4.9.5. Japan Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.4.10. Rest of APAC
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.4.10.3. Rest of APAC Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.4.10.4. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.4.10.5. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
10.5.4. Latin America Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.5.5. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.5.6. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.5.10. Rest of Europe
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.5.10.4. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US Billion)
10.5.10.5. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US Billion)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Billion)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Billion)
10.6.9. Rest of MEA
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
10.6.9.3. Rest of MEA Market Size and Forecast, By Test Type, 2016 - 2027 (US$ Billion)
10.6.9.4. Rest of MEA Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
10.6.9.5. Rest of MEA Market Size and Forecast, By Application, 2016 - 2027 (US$ Billion)
11. KEY VENDOR ANALYSIS
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Siemens Healthiness
11.2.1.1. Company Snapshot
11.2.1.2. Financial Performance
11.2.1.3. Product Benchmarking
11.2.1.4. Strategic Initiatives
11.2.2. Roche Diagnostics Limited
11.2.3. Abbott Laboratories
11.2.4. Danaher Corporation
11.2.5. Johnson & Johnson
11.2.6. Thermo Fisher Scientific
11.2.7. Dickinson and Company
11.2.8. Becton
11.2.9. Sysmex Corporation
11.2.10. Bio-Rad Laboratories
11.2.11. Diasorin
11.2.12. bioMérieux
11.2.13. Ortho-Clinical Diagnostics
11.2.14. Qiagen
12. 360 DEGREE ANALYST VIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
